• Tioconazole: Molecular Insights and Next-Gen Antifungal Mode

  2026-04-23

  Explore Tioconazole as a benchmark antifungal medication—this article uncovers its molecular action, rigorous research applications, and translational insights that advance antifungal drug development beyond standard protocols.

• Plk1 Regulation of p31comet in Mitotic Checkpoint Disassembl

  2026-04-22

  This study reveals how Polo-like kinase 1 (Plk1) directly phosphorylates and inhibits the Mad2-binding protein p31comet, limiting its ability to disassemble mitotic checkpoint complexes. The findings clarify the molecular coordination that ensures proper chromosome segregation during mitosis and provide new insights into regulatory mechanisms of cell cycle progression.

• Spermine Tetrahydrochloride: Protocols and Innovations for P

  2026-04-22

  Spermine tetrahydrochloride sets a new benchmark for reproducible membrane protection, protein crystallization, and nanoparticle crosslinking workflows. Leveraging its charge-based interactions, it delivers superior stability and activity retention in challenging biological and material science assays—outperforming related polyamines and enabling translational advances in both neuroscience and nanomedicine.

• Indole-3-pyruvic Acid Mitigates RA via Aryl Hydrocarbon Rece

  2026-04-21

  This study demonstrates that indole-3-pyruvic acid (IPA), a tryptophan-derived metabolite, alleviates rheumatoid arthritis (RA) by modulating the Th17/Treg cell balance through activation of the aryl hydrocarbon receptor (AhR) pathway. The findings provide mechanistic evidence for IPA as a potential immunomodulatory agent in RA, with practical implications for translational research.

• Caspofungin: Lipopeptide Antifungal Drug for β-Glucan Inhibi

  2026-04-21

  Caspofungin is a selective lipopeptide antifungal drug that inhibits β-1,3-glucan synthase, disrupting fungal cell wall biosynthesis. This agent demonstrates potent efficacy against azole-resistant Candida, with benchmarked IC50 and MIC90 values in laboratory models. Its application in antifungal therapeutics research is supported by robust protocols and comparative studies.

• Ibrexafungerp and Caspofungin: Efficacy Against Resistant Ca

  2026-04-20

  Wiederhold et al. demonstrate that ibrexafungerp exhibits potent in vitro and in vivo activity against fluconazole-resistant Candida auris, even with delayed therapy initiation. The study provides critical protocol and efficacy data for antifungal agents targeting the β-(1,3)-D-glucan biosynthesis pathway, with practical benchmarks for research on azole-resistant Candida infections.

• Prochlorperazine as a Dopamine D2 Receptor Antagonist in Can

  2026-04-20

  Prochlorperazine’s robust profile as a dopamine D2 receptor antagonist enables precise control in both antiemetic therapy and advanced cancer research. Explore workflow-ready protocol enhancements, troubleshooting strategies, and critical safety insights that empower researchers to achieve reproducible, data-driven results with APExBIO’s validated reagent.

• MLN4924 HCl Salt: Precision NEDD8-Activating Enzyme Inhibiti

  2026-04-19

  MLN4924 HCl salt empowers researchers to dissect neddylation pathway inhibition in real time, enabling high-specificity modulation of cullin-RING ligases and protein degradation in cancer biology research. This guide delivers hands-on workflows, protocol optimizations, and troubleshooting rooted in peer-reviewed data and recent advances in viral immunity.

• Deep Learning Identifies Cardiotoxicity in iPSC-CMs Screenin

  2026-04-18

  This study demonstrates the integration of deep learning with high-content imaging to sensitively detect cardiotoxic effects in induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). The approach enables early, scalable identification of drug-induced toxicity, improving risk assessment in drug discovery.

• Mitochondrial Membrane Potential: From Mechanism to Translat

  2026-04-17

  This thought-leadership article explores how advances in mitochondrial membrane potential (ΔΨm) analysis, exemplified by the TMRE mitochondrial Membrane Potential Assay Kit, are redefining translational research. By weaving mechanistic insights from recent studies—including sodium-driven NECSO-induced mitochondrial dysfunction—into strategic experimental frameworks, the article guides translational scientists in leveraging high-content ΔΨm assays for apoptosis research, disease modeling, and therapeutic innovation. The piece also critically contrasts competitive assays, addresses workflow challenges, and forecasts the evolving landscape of mitochondrial research.

• Targeting FGFR2 Fusions in ICC via Heteroduplex Oligonucleot

  2026-04-16

  The referenced study introduces a cholesterol-conjugated DNA/RNA heteroduplex oligonucleotide (Cho-HDO) that specifically targets FGFR2-AHCYL1 fusion transcripts in intrahepatic cholangiocarcinoma (ICC). By coupling this approach with asparagine depletion, the study delineates a potent synergistic strategy to restrict tumor growth and overcome bypass resistance mechanisms in FGFR2 fusion-driven ICC.

• Ertugliflozin Cardiovascular Outcomes in Type 2 Diabetes: VE

  2026-04-15

  The VERTIS CV trial rigorously evaluated the cardiovascular safety of ertugliflozin, a selective SGLT2 inhibitor, in patients with type 2 diabetes and established atherosclerotic cardiovascular disease. Key findings demonstrated noninferiority to placebo for major adverse cardiovascular events, offering important evidence for clinicians and researchers regarding SGLT2 inhibitor use in high-risk diabetic populations.

• Cy5-UTP: Illuminating RNA Structure and Dynamics with Precis

  2026-04-14

  Explore how Cy5-UTP (Cyanine 5-uridine triphosphate) enables single-molecule insights into RNA folding and gene regulation. This in-depth guide uniquely connects advanced fluorescent RNA labeling to mechanistic discoveries in riboswitch biology.

• Phosbind Biotin LC: Practical Guide for Phosphorylation Dete

  2026-04-13

  Phosbind Biotin LC is a phosphate-binding reagent for sensitive, sequence-independent detection of phosphorylated proteins on PVDF membranes, primarily in Western Blot applications. It provides an alternative to phospho-specific antibodies, particularly when antibody availability or sequence specificity is a limitation. This reagent should not be used in aqueous-only protocols or stored as a working solution.

• Doxorubicin Hydrochloride: Optimized Workflows for Cancer an

  2026-04-13

  Doxorubicin hydrochloride (Adriamycin HCl) stands as a gold-standard DNA topoisomerase II inhibitor, supporting advanced cancer chemotherapy research and robust cardiotoxicity modeling. This article delivers actionable experimental workflows, protocol enhancements, and troubleshooting guidance for maximizing data quality using APExBIO’s research-grade Doxorubicin (Adriamycin) HCl.

15622 records 1/1042 page Next 12345 下5页 Last page